Chordomas are rare tumors that usually occur in adults. This report de
scribes four cases of intracranial chordomas treated in patients 20 ye
ars of age or younger by the senior author (O.A.M.) during a 4-year pe
riod. The authors also reviewed the literature on pediatric patients,
which revealed that the clinical presentations, histological patterns,
and behaviors of these tumors differ considerably depending on whethe
r the patient is younger or older than 5 years of age. The younger pop
ulation had a wider range of presenting symptoms, a greater prevalence
of atypical histological findings with aggressive behavior, a greater
range of cellularity than the classic chordomas, and a higher instanc
e of metastasis; it showed no chondroid component compared to a 17.1%
instance in the older patients. The prognosis for patients with a chor
doma is related directly to the histological pattern of the tumor, the
atypical chordoma carries a poor prognosis. The prognoses for childre
n older than 5 years of age with a classic or chondroid tumor were not
significantly different (p = 0.788). At follow up, the difference in
survival rates between patients undergoing surgery plus radiation ther
apy and those who had surgery alone was statistically significant (p =
0.00446). No correlation was found between radical resection or radia
tion therapy and an improved prognosis for patients younger than 5 yea
rs of age who had a tumor with an atypical histological pattern. This
study identifies and delineates the distinction between these age grou
ps and provides a review of the potential prognostic factors.